Company Filing History:
1 out of 850 
1 out of 832,843 Years Active: 2011-2013
Title: The Innovative Contributions of Aurelia Chevalier
Introduction
Aurelia Chevalier is a notable inventor based in Dreux, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of chemokine receptor antagonists. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Aurelia's latest patents include innovative formulations of chemokine receptor antagonists. One of her notable inventions is the citrate salt of (S)-4-(4-Chloro-phenyl)-1-{3-[7-(1-hydroxy-1-methyl-ethyl)-11H-10-oxa-1-aza-dibenzo[a,d]cyclohepten-5-ylidene]-propyl}-3,3-dimethyl-piperidin-4-ol. This compound has potential applications in treating diseases associated with aberrant leukocyte recruitment and activation. The patent discusses various crystalline forms of the citrate salt, methods for producing these forms, and their therapeutic uses.
Career Highlights
Throughout her career, Aurelia has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited. Her expertise in the field has led to significant advancements in drug development and therapeutic applications.
Collaborations
Aurelia has collaborated with several professionals in her field, including Carole Neves and Pascal Billot. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Aurelia Chevalier's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her work continues to influence the development of new treatments for various medical conditions.